{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:36:24Z","timestamp":1787819784205,"version":"build-2784847793"},"reference-count":34,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,13]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background:<\/jats:title><jats:p>COVID-19\u2013related acute illness is associated with an increased risk of venous thromboembolism (VTE).<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>These evidence-based guidelines from the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in making decisions about the use of anticoagulation in patients with COVID-19.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>ASH formed a multidisciplinary guideline panel that included patient representatives and applied strategies to minimize potential bias from conflicts of interest. The McMaster University GRADE Centre supported the guideline development process and performed systematic evidence reviews (through November 2021). The panel prioritized clinical questions and outcomes according to their importance for clinicians and patients. The panel used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to assess evidence and make recommendations, which were subject to public comment. This is an update to guidelines published in February 2021 as part of the living phase of these guidelines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The panel made one additional recommendation. The panel issued a conditional recommendation in favor of therapeutic-intensity over prophylactic-intensity anticoagulation in patients with COVID-19\u2013related acute illness who do not have suspected or confirmed VTE. The panel emphasized the need for an individualized assessment of risk of thrombosis and bleeding. The panel also noted that heparin (unfractionated or low molecular weight) may be preferred because of a preponderance of evidence with this class of anticoagulants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>This conditional recommendation was based on very low certainty in the evidence, underscoring the need for additional, high-quality, randomized controlled trials comparing different intensities of anticoagulation in patients with COVID-19\u2013related acute illness.<\/jats:p><\/jats:sec>","DOI":"10.1182\/bloodadvances.2022007561","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T14:03:13Z","timestamp":1651586593000},"page":"4915-4923","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":58,"title":["American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3595-5697","authenticated-orcid":false,"given":"Adam","family":"Cuker","sequence":"first","affiliation":[{"name":"1Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2745-8057","authenticated-orcid":false,"given":"Eric K.","family":"Tseng","sequence":"additional","affiliation":[{"name":"2Division of Hematology\/Oncology, St. Michael\u2019s Hospital, University of Toronto, Toronto, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robby","family":"Nieuwlaat","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantep","family":"Angchaisuksiri","sequence":"additional","affiliation":[{"name":"4Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifton","family":"Blair","sequence":"additional","affiliation":[{"name":"5Union, NJ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Dane","sequence":"additional","affiliation":[{"name":"6Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T.","family":"DeSancho","sequence":"additional","affiliation":[{"name":"7Division of Hematology-Oncology, Department of Medicine, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Diuguid","sequence":"additional","affiliation":[{"name":"8Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5853-6906","authenticated-orcid":false,"given":"Daniel O.","family":"Griffin","sequence":"additional","affiliation":[{"name":"9Division of Infectious Diseases, College of Physicians & Surgeons of Columbia University, New York, NY;"},{"name":"10Research and Development at United Health Group, Minnetonka, MN;"},{"name":"11Prohealth NY, Lake Success, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R.","family":"Kahn","sequence":"additional","affiliation":[{"name":"12Department of Medicine, McGill University, Montreal, QC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9961-0754","authenticated-orcid":false,"given":"Frederikus A.","family":"Klok","sequence":"additional","affiliation":[{"name":"13Department of Medicine \u2013 Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5968-3948","authenticated-orcid":false,"given":"Alfred Ian","family":"Lee","sequence":"additional","affiliation":[{"name":"14Section of Hematology, Yale School of Medicine, New Haven, CT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Neumann","sequence":"additional","affiliation":[{"name":"15Department of Internal Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Pai","sequence":"additional","affiliation":[{"name":"16Division of Hematology & Oncology, Kaiser Permanente, Oakland\/Richmond, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Righini","sequence":"additional","affiliation":[{"name":"17Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0433-7845","authenticated-orcid":false,"given":"Kristen M.","family":"Sanfilippo","sequence":"additional","affiliation":[{"name":"18Washington University School of Medicine St. Louis, St. Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3806-3245","authenticated-orcid":false,"given":"Deborah M.","family":"Siegal","sequence":"additional","affiliation":[{"name":"19Department of Medicine and the Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Skara","sequence":"additional","affiliation":[{"name":"20Cottage Grove, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0794-5851","authenticated-orcid":false,"given":"Deirdra R.","family":"Terrell","sequence":"additional","affiliation":[{"name":"21Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamshad","family":"Touri","sequence":"additional","affiliation":[{"name":"22Toronto, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3444-8618","authenticated-orcid":false,"given":"Elie A.","family":"Akl","sequence":"additional","affiliation":[{"name":"23Department of Internal Medicine, American University of Beirut, Beirut, Lebanon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyad","family":"Al Jabiri","sequence":"additional","affiliation":[{"name":"24University of Jordan, Amman, Jordan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan","family":"Al Jabiri","sequence":"additional","affiliation":[{"name":"25Lincoln Medical Center, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Barbara","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0128-903X","authenticated-orcid":false,"given":"Antonio","family":"Bognanni","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5046-598X","authenticated-orcid":false,"given":"Mary","family":"Boulos","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6010-9900","authenticated-orcid":false,"given":"Romina","family":"Brignardello-Petersen","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5512-0091","authenticated-orcid":false,"given":"Rana","family":"Charide","sequence":"additional","affiliation":[{"name":"26Clinical Research Institute, American University of Beirut, Beirut, Lebanon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7737-4914","authenticated-orcid":false,"given":"Luis E.","family":"Colunga-Lozano","sequence":"additional","affiliation":[{"name":"27Department of Clinical Medicine, Health Science Center, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6854-0156","authenticated-orcid":false,"given":"Karin","family":"Dearness","sequence":"additional","affiliation":[{"name":"28Library Services, St. Joseph\u2019s Healthcare Hamilton, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2498-1697","authenticated-orcid":false,"given":"Andrea J.","family":"Darzi","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6042-361X","authenticated-orcid":false,"given":"Heba","family":"Hussein","sequence":"additional","affiliation":[{"name":"29Oral Medicine and Periodontology Department, Faculty of Dentistry, Cairo University, Cairo, Egypt;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5167-4246","authenticated-orcid":false,"given":"Samer G.","family":"Karam","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7719-9068","authenticated-orcid":false,"given":"Razan","family":"Mansour","sequence":"additional","affiliation":[{"name":"30Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman, Jordan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7577-7963","authenticated-orcid":false,"given":"Gian Paolo","family":"Morgano","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2131-3711","authenticated-orcid":false,"given":"Rami Z.","family":"Morsi","sequence":"additional","affiliation":[{"name":"31Department of Neurology, University of Chicago, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Muti-Sch\u00fcnemann","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1506-3613","authenticated-orcid":false,"given":"Menatalla K.","family":"Nadim","sequence":"additional","affiliation":[{"name":"32Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binu A.","family":"Philip","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9572-9106","authenticated-orcid":false,"given":"Yuan","family":"Qiu","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yetiani Roldan","family":"Benitez","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6257-4806","authenticated-orcid":false,"given":"Adrienne","family":"Stevens","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6134-9140","authenticated-orcid":false,"given":"Karla","family":"Solo","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6576-1650","authenticated-orcid":false,"given":"Wojtek","family":"Wiercioch","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2091-0875","authenticated-orcid":false,"given":"Reem A.","family":"Mustafa","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada;"},{"name":"33Department of Internal Medicine, Division of Nephrology, University of Kansas Medical Center, Kansas City, KS;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3211-8479","authenticated-orcid":false,"given":"Holger J.","family":"Sch\u00fcnemann","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton, ON, Canada;"},{"name":"34Institut f\u00fcr Evidence in Medicine, Medical Center & Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"issue":"7","key":"2022082615225501000_B1","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/rth2.12439","article-title":"Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis","volume":"4","author":"Nopp","year":"2020","journal-title":"Res Pract Thromb Haemost."},{"issue":"3","key":"2022082615225501000_B2","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.chest.2020.11.005","article-title":"Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis","volume":"159","author":"Jim\u00e9nez","year":"2021","journal-title":"Chest."},{"issue":"3","key":"2022082615225501000_B3","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/bloodadvances.2020003763","article-title":"American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19","volume":"5","author":"Cuker","year":"2021","journal-title":"Blood Adv."},{"key":"2022082615225501000_B4","article-title":"Clinical Practice Guidelines We Can Trust","author":"Institute of Medicine","year":"2011"},{"issue":"7","key":"2022082615225501000_B5","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/M14-1885","article-title":"Guidelines International Network: principles for disclosure of interests and management of conflicts in guidelines","volume":"163","author":"Sch\u00fcnemann","year":"2015","journal-title":"Ann Intern Med."},{"issue":"7","key":"2022082615225501000_B6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-156-7-201204030-00009","article-title":"Guidelines International Network: toward international standards for clinical practice guidelines","volume":"156","author":"Qaseem","year":"2012","journal-title":"Ann Intern Med."},{"key":"2022082615225501000_B7","doi-asserted-by":"crossref","first-page":"i2016","DOI":"10.1136\/bmj.i2016","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: introduction","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ."},{"key":"2022082615225501000_B8","doi-asserted-by":"crossref","first-page":"i2089","DOI":"10.1136\/bmj.i2089","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: clinical practice guidelines","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ."},{"issue":"1","key":"2022082615225501000_B9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6963-4-38","article-title":"Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group","volume":"4","author":"Atkins","year":"2004","journal-title":"BMC Health Serv Res."},{"issue":"7","key":"2022082615225501000_B10","first-page":"677","article-title":"Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations","volume":"169","author":"Sch\u00fcnemann","year":"2003","journal-title":"CMAJ."},{"key":"2022082615225501000_B11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.09.009","article-title":"GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT","volume":"81","author":"Sch\u00fcnemann","year":"2017","journal-title":"J Clin Epidemiol."},{"issue":"4","key":"2022082615225501000_B12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol."},{"issue":"7650","key":"2022082615225501000_B13","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ."},{"key":"2022082615225501000_B14","article-title":"ASH Guidelines on the Use of Anticoagulation in Patients With COVID-19","author":"American Society of Hematology"},{"key":"2022082615225501000_B15","article-title":"COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)","author":"Johns Hopkins University of Medicine, Coronavirus Resource Center"},{"issue":"2","key":"2022082615225501000_B16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/a-1667-7534","article-title":"Therapeutic versus prophylactic bemiparin in hospitalized patients with nonsevere COVID-19 pneumonia (BEMICOP study): an open-label, multicenter, randomized, controlled trial","volume":"122","author":"Marcos-Jubilar","year":"2022","journal-title":"Thromb Haemost."},{"issue":"2400","key":"2022082615225501000_B17","doi-asserted-by":"crossref","first-page":"n2400","DOI":"10.1136\/bmj.n2400","article-title":"Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial","volume":"375","author":"Sholzberg","year":"2021","journal-title":"BMJ."},{"issue":"9","key":"2022082615225501000_B18","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with COVID-19","volume":"385","author":"Lawler","year":"2021","journal-title":"N Engl J Med."},{"issue":"12","key":"2022082615225501000_B19","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jamainternmed.2021.6203","article-title":"Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID randomized clinical trial","volume":"181","author":"Spyropoulos","year":"2021","journal-title":"JAMA Intern Med."},{"issue":"10291","key":"2022082615225501000_B20","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(21)01203-4","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial","volume":"397","author":"Lopes","year":"2021","journal-title":"Lancet."},{"issue":"20","key":"2022082615225501000_B21","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/bloodadvances.2021005493","article-title":"American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients","volume":"5","author":"Cuker","year":"2021","journal-title":"Blood Adv."},{"issue":"32","key":"2022082615225501000_B22","doi-asserted-by":"crossref","first-page":"E901","DOI":"10.1503\/cmaj.200077","article-title":"Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses","volume":"192","author":"Schandelmaier","year":"2020","journal-title":"CMAJ."},{"issue":"9","key":"2022082615225501000_B23","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/bloodadvances.2020001755","article-title":"A user guide to the American Society of Hematology clinical practice guidelines","volume":"4","author":"Izcovich","year":"2020","journal-title":"Blood Adv."},{"issue":"8","key":"2022082615225501000_B24","doi-asserted-by":"crossref","first-page":"e12638","DOI":"10.1002\/rth2.12638","article-title":"Randomized trials of therapeutic heparin for COVID-19: a meta-analysis","volume":"5","author":"Sholzberg","year":"2021","journal-title":"Res Pract Thromb Haemost."},{"key":"2022082615225501000_B25","doi-asserted-by":"crossref","first-page":"pvab070","DOI":"10.1093\/ehjcvp\/pvab070","article-title":"Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials","author":"Ortega-Paz","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"issue":"3","key":"2022082615225501000_B26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/cpt.2504","article-title":"Anticoagulant treatment regimens in patients with COVID-19: a meta-analysis","volume":"111","author":"Jorda","year":"2022","journal-title":"Clin Pharmacol Ther."},{"issue":"2","key":"2022082615225501000_B27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jiac.2021.11.008","article-title":"The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials","volume":"28","author":"Kow","year":"2022","journal-title":"J Infect Chemother."},{"key":"2022082615225501000_B28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pmedr.2019.01.006","article-title":"Lower risk of venous thromboembolism in multiple Asian ethnic groups","volume":"13","author":"Tran","year":"2019","journal-title":"Prev Med Rep."},{"issue":"2","key":"2022082615225501000_B29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/rth2.12486","article-title":"Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19","volume":"5","author":"Spyropoulos","year":"2021","journal-title":"Res Pract Thromb Haemost."},{"issue":"1","key":"2022082615225501000_B30","doi-asserted-by":"crossref","first-page":"e706","DOI":"10.1002\/ams2.706","article-title":"Japanese rapid\/living recommendations on drug management for COVID-19: updated guidelines (September 2021)","volume":"8","author":"Yamakawa","year":"2021","journal-title":"Acute Med Surg."},{"issue":"4","key":"2022082615225501000_B31","doi-asserted-by":"crossref","first-page":"2100048","DOI":"10.1183\/13993003.00048-2021","article-title":"Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline","volume":"57","author":"Chalmers","year":"2021","journal-title":"Eur Respir J."},{"issue":"4","key":"2022082615225501000_B32","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s40121-021-00487-7","article-title":"Clinical management of adult patients with COVID-19 outside intensive care units: guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)","volume":"10","author":"Bassetti","year":"2021","journal-title":"Infect Dis Ther."},{"issue":"4","key":"2022082615225501000_B33","doi-asserted-by":"crossref","first-page":"100919","DOI":"10.1016\/j.accpm.2021.100919","article-title":"Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: updated proposals (April 2021): from the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French Society of Anaesthesia and Intensive Care (SFAR)","volume":"40","author":"Godon","year":"2021","journal-title":"Anaesth Crit Care Pain Med."},{"key":"2022082615225501000_B34","article-title":"Antithrombotic Therapy in Patients With COVID-19","author":"National Institutes of Health, COVID-19 Treatment Guidelines"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/17\/4915\/1916887\/advancesadv2022007561c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/17\/4915\/1916887\/advancesadv2022007561c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T23:54:12Z","timestamp":1700524452000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/17\/4915\/485124\/American-Society-of-Hematology-living-guidelines"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":34,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2022,9,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022007561","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]}}}